Steven Sell steps down as President, Chief Executive Officer, and Board Director
Ronald A. Williams, co-founder, Board Chairman, and healthcare industry veteran, appointed Executive Chairman
Board establishes an Office of the Chairman and initiates search for permanent CEO
Company reports second quarter 2025 earnings and withdraws full year 2025 guidance
agilon health (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that Steven Sell has stepped down as President, CEO, and a Director of the Board. Ronald A. Williams, the Company’s co-founder and Board Chairman since 2017, has been appointed Executive Chairman. Williams is an industry veteran with leadership experience at healthcare and technology companies including Aetna, where he was Chairman and CEO.
agilon’s Board of Directors has established an Office of the Chairman to assume Sell’s responsibilities on an interim basis and accelerate execution of the Company’s priorities. The Office, led by Williams, includes Jeff Schwaneke, Chief Financial Officer; Heidi Hittner, Executive Vice President and Chief of Staff; Karthik Rao, M.D., Chief Medical Officer; Ben Shaker, Chief Markets Officer; Girish Venkatachaliah, Chief Technology Officer; and Denise Zamore, Chief Legal Officer and Corporate Secretary. The Board of Directors has initiated a search for a permanent CEO and is working with a leading executive search firm to assist in the process.
“On behalf of the Board, I want to thank Steve for his leadership and partnership over the last several years,” said Williams. “During his tenure, agilon expanded our value-based care model, broadened our partnerships with primary care physicians across the country, and built a deep and talented team. We wish him well in his future endeavors.”
Williams continued, “The U.S. healthcare system is grappling with an aging population, increasing chronic conditions, and rising costs. agilon is helping address a critical need among primary care physicians, Medicare members and payors with our Total Care Model that enables high-quality and cost-efficient care. We are committed to driving the operational improvements that will enable agilon to capitalize on the significant opportunities ahead and create value for our stakeholders as the market stabilizes. I look forward to working more closely with our leadership team and physician partners to ensure that the critical investments we are making position agilon to improve execution and drive sustainable long-term performance. We will work quickly to conduct a thorough search and identify a new CEO to lead agilon forward.”
“Ron’s deep understanding of our industry and proven track record of leading transformational, profitable growth make him well-suited to guide agilon through this transition,” said Ravi Sachdev, agilon’s founder and Vice Chairman of the Board. “He has influenced agilon’s mission from the start, and in this enhanced role he will execute performance improvements and support our physician partners in driving continuously improving total cost of care outcomes in their communities.”
In a separate press release, the Company today also issued its second quarter 2025 earnings results. As part of that announcement, and in conjunction with this leadership transition, the Company is withdrawing its previous full year 2025 earnings guidance.
